Pancreas divisum

Current Gastroenterology Reports

Volumn 13, Issue 2, 2011, Pages 150-156

  DiMagno, Matthew J ^a   Wamsteker, Erik Jan ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Acute pancreatitis; Chronic pancreatitis; Pancreas divisum; Sphincterotomy

Indexed keywords

LOXIGLUMIDE; OCTREOTIDE; PLACEBO; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CLINICAL OBSERVATION; DISEASE ASSOCIATION; DISEASE COURSE; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MUTATIONAL ANALYSIS; PANCREAS DIVISUM; PANCREATITIS; PLACEBO EFFECT; REVIEW; TREATMENT OUTCOME;

DIGESTIVE SYSTEM ABNORMALITIES; ENDOSCOPY, DIGESTIVE SYSTEM; HUMANS; MUTATION; PANCREATIC DUCTS; PANCREATITIS; PLACEBO EFFECT;

EID: 79955828892     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-010-0170-8     Document Type: Review

References (56)

1. Fogel EL, Toth TG, Lehman GA, et al.: Does endoscopic therapy favorably affect the outcome of patients who have recurrent acute pancreatitis and pancreas divisum? Pancreas (2007) 34(1):21-45. To address an important and long-standing controversy in clinical pancreatology, this two-part discussion focuses on data and arguments for and against endoscopic therapy for patients with recurrent acute pancreatitis and PD. Coauthors Fogel, Toth, and Lehman report "The Case for Endoscopic Therapy" and coauthors DiMagno and DiMagno report "The Cases Against Endoscopic Therapy." The section by DiMagno and DiMagno also includes multiple new analyses of the world's literature to report prevalence data of PD in idiopathic pancreatitis based on whether data were derived from autopsy, endoscopic, or MRCP literature.
2. Layer P, Yamamoto H, Kalthoff L, et al.: The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology (1994) 107(5):1481-1487. (Pubitemid 24328288)
3. DiMagno MJ, Wamsteker EJ, Lee A: Chronic Pancreatitis. BMA House, London (2009). https://online.epocrates.com/u/291167/Chronic+pancreatitis
4. Cotton PB: Congenital anomaly of pancreas divisum as cause of obstructive pain and pancreatitis. Gut (1980) 21(2):105-114.
5. Sahel J, Cros RC, Bourry J, Sarles H: Clinico-pathological conditions associated with pancreas divisum. Digestion (1982) 23(1):1-8. (Pubitemid 12150619)
6. Richter JM, Schapiro RH, Mulley AG, Warshaw AL: Association of pancreas divisum and pancreatitis, and its treatment by sphincteroplasty of the accessory ampulla. Gastroenterology (1981) 81(6):1104-1110. (Pubitemid 11029692)
7. Burtin P, Person B, Charneau J, Boyer J: Pancreas divisum and pancreatitis: a coincidental association? Endoscopy (1991) 23 (2):55-58.
8. Delhaye M, Engelholm L, Cremer M: Pancreas divisum: congenital anatomic variant or anomaly? Contribution of endoscopic retrograde dorsal pancreatography. Gastroenterology (1985) 89(5):951-958. (Pubitemid 16231554)
9. Sugawa C, Walt AJ, Nunez DC, Masuyama H: Pancreas divisum: is it a normal anatomic variant? Am J Surg (1987) 153(1):62-67.
10. Bernard JP, Sahel J, Giovannini M, Sarles H: Pancreas divisum is a probable cause of acute pancreatitis: a report of 137 cases. Pancreas (1990) 5(3):248-254. (Pubitemid 20149057)
11. Liao Z, Gao R, Wang W, et al.: A systematic review on endoscopic detection rate, endotherapy, and surgery for pancreas divisum. Endoscopy (2009) 41(5):439-444. A systematic review of ERCP detection rates for PD reported a 2.9% prevalence of PD out of 31,413 ERCPs from 17 studies. PD prevalence varied by different geographic regions, but these apparent regional differences are likely attributable to the degree that endoscopists search for PD (by examining both ductal systems), to referral bias, or to other factors.
12. Ammann RW: Alcoholic chronic pancreatitis: its relation to alcoholic acute pancreatitis. Gastroenterol Clin Biol (1996) 20 (3):312-314.
13. Comfort MW, Gambill EE, Baggenstoss AH: Chronic relapsing pancreatitis: a study of 29 cases without associated disease of the biliary or gastro-intestinal tract (continued). Gastroenterology (1946) 6(376-408.
14. Barthet M, Valantin V, Spinosa S, et al.: Clinical course and morphological features of chronic calcifying pancreatitis associated with pancreas divisum. Eur J Gastroenterol Hepatol (1995) 7 (10):993-998.
15. Spicak J, Poulova P, Plucnarova J, et al.: Pancreas divisum does not modify the natural course of chronic pancreatitis. J Gastroenterol (2007) 42(2):135-139. In a population with predominantly alcoholic chronic pancreatitis, groups with and without PD showed no significant differences among gender, age at onset of disease, clinical presentation, course of disease, and frequency of complications.
16. Draganov P, Forsmark CE: "Idiopathic" pancreatitis. Gastroenterology (2005) 128(3):756-763.
17. Vila JJ, Vicuna M, Irisarri R, et al.: Diagnostic yield and reliability of endoscopic ultrasonography in patients with idiopathic acute pancreatitis. Scand J Gastroenterol (2010) 45(3):375-381.
18. Yadav D, Lowenfels AB: Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas (2006) 33(4):323-330. (Pubitemid 44690719)
19. Garg PK, Tandon RK,Madan K: Is biliary microlithiasis a significant cause of idiopathic recurrent acute pancreatitis? A long-term followup study. Clin Gastroenterol Hepatol (2007) 5(1):75-79. (Pubitemid 46096821)
20. Jacob L, Geenen JE, Catalano MF, Geenen DJ: Prevention of pancreatitis in patients with idiopathic recurrent pancreatitis: a prospective nonblinded randomized study using endoscopic stents. Endoscopy (2001) 33(7):559-562. (Pubitemid 32618919)
21. Yusoff IF, Raymond G, Sahai AV: A prospective comparison of the yield of EUS in primary vs. recurrent idiopathic acute pancreatitis. Gastrointest Endosc (2004) 60(5):673-678. (Pubitemid 39550922)
22. Whitcomb DC, Gorry MC, Preston RA, et al.: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet (1996) 14(2):141-145. (Pubitemid 26338792)
23. Simon P, Weiss FU, Zimmer KP, et al.: Spontaneous and sporadic trypsinogen mutations in idiopathic pancreatitis. JAMA (2002) 288(17):2122. (Pubitemid 35265378)
24. Cohn JA, Friedman KJ, Noone PG, et al.: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med (1998) 339(10):653-658. (Pubitemid 28402089)
25. Sharer N, Schwarz M, Malone G, et al.: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med (1998) 339(10):645-652. (Pubitemid 28402088)
26. Witt H, Luck W, Hennies HC, et al.: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet (2000) 25(2):213-216.
27. Rossi L, Pfutzer RH, Parvin S, et al.: SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report. Pancreatology (2001) 1(3):242-245. (Pubitemid 33674928)
28. Noone PG, Zhou Z, Silverman LM, et al.: Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology (2001) 121 (6):1310-1319. (Pubitemid 33140448)
29. DiMagno EP: Gene mutations and idiopathic chronic pancreatitis: clinical implications and testing. Gastroenterology (2001) 121 (6):1508-1512.
30. Bishop MD, Freedman SD, Zielenski J, et al.: The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum Genet (2005) 1-10.
31. Choudari CP, Imperiale TF, Sherman S, et al.: Risk of pancreatitis with mutation of the cystic fibrosis gene. Am J Gastroenterol (2004) 99(7):1358-1363. (Pubitemid 39062277)
32. Aoun E, Muddana V, Papachristou GI, Whitcomb DC: SPINK1 N34S is strongly associated with recurrent acute pancreatitis but is not a risk factor for the first or sentinel acute pancreatitis event. Am J Gastroenterol (2010) 105(2):446-451.
33. Steinberg WM, Chari ST, Forsmark CE, et al.: Controversies in clinical pancreatology: management of acute idiopathic recurrent pancreatitis. Pancreas (2003) 27(2):103-117. (Pubitemid 36950720)
34. Pezzilli R,Morselli-LabateAM, MantovaniV, et al.:Mutations of the CFTR gene in pancreatic disease. Pancreas (2003) 27(4):332-336.
35. Kopelman H, Durie P, Gaskin K, et al.: Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. New England Journal of Medicine (1985) 312(6):329-334. (Pubitemid 15152645)
36. DiMagno MJ, Lee SH, Hao Y, et al.: A proinflammatory, antiapoptotic phenotype underlies the susceptibility to acute pancreatitis in cystic fibrosis transmembrane regulator (-/-) mice. Gastroenterology (2005) 129(2):665-681. (Pubitemid 41096651)
37. DiMagno MJ, Lee SH, Owyang C, Zhou SY: Inhibition of acinar apoptosis occurs during acute pancreatitis in the human homologue DeltaF508 cystic fibrosis mouse. Am J Physiol Gastrointest Liver Physiol (2010) 299(2):G400-412.
38. Rosendahl J, Witt H, Szmola R, et al: Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet (2008) 40(1):78-82.
39. Felderbauer P, Hoffmann P, Einwachter H, et al.: A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. BMC Gastroenterol (2003) 3(1):34.
40. Muddana V, Lamb J, Greer JB, et al.: Association between calcium sensing receptor gene polymorphisms and chronic pancreatitis in a US population: role of serine protease inhibitor Kazal 1type and alcohol. World J Gastroenterol (2008) 14 (28):4486-4491.
41. Groman JD, Meyer ME, Wilmott RW, et al.: Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med (2002) 347(6):401-407. (Pubitemid 34851832)
42. Knowles MR, Durie PR: What is cystic fibrosis? N Engl J Med (2002) 347(6):439-442.
43. Ko SB, Mizuno N, Yatabe Y, et al.: Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology (2010) 138 (5):1988-1996.
44. Gelrud A, Sheth S, Banerjee S, et al: Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis. Am J Gastroenterol (2004) 99 (8):1557-1562. (Pubitemid 39180107)
45. Garg PK, Khajuria R, Kabra M, et al.: Association of SPINK1 gene mutation and CFTR gene polymorphisms in patients with pancreas divisum presenting with idiopathic pancreatitis. J Clin Gastroenterol, 2009. 43(9): p. 848-52.
46. Wilcox CM: Endoscopic therapy for pain in chronic pancreatitis: Is it time for the naysayers to throw in the towel? Gastrointest Endosc (2005) 61(4):582-586.
47. Toskes PP, Forsmark CE, DeMeo MT, et al: An open-label trial of octreotide for the pain of chronic pancreatitis. Gastroenterology (1994) 106(A326.
48. Shiratori K, Takeuchi T, Satake K, Matsuno S: Clinical evaluation of oral administration of a cholecystokinin-A receptor antagonist (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicenter dose-response study in Japan. Pancreas (2002) 25(1):e1-5.
49. Bhardwaj P, Garg PK, Maulik SK, et al.: A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology (2009) 136(1):149-159 e142.
50. Cahen DL, Gouma DJ, Nio Y, et al.: Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med (2007) 356(7):676-684.
51. Cooperman AM, Siegel J, Hammerman H: Pancreas divisum-advocates and agnostics. J Clin Gastroenterol (1989) 11(5):489-491.
52. Chacko LN, Chen YK, Shah RJ: Clinical outcomes and nonendoscopic interventions after minor papilla endotherapy in patients with symptomatic pancreas divisum. Gastrointest Endosc (2008) 68(4):667-673. The authors report that minor papilla endotherapy of patients with PD results in a clinical response or improvement in 76% with IRAP, but only 42% of those with chronic pancreatitis and 33% with chronic abdominal pain. The authors conclude that endoscopic therapy is a reasonable first step in the absence of chronic pain, but also acknowledge that short-term follow-up may be inadequate to assess response in some patients with IRAP who have long pain-free intervals and/or develop chronic pain.
53. Ahmed F, Sherman S: Minor papilla endotherapy in patients with symptomatic pancreas divisum. Gastrointest Endosc (2008) 68 (4):674-675.
54. Delhaye M, Matos C, Arvanitakis M, Deviere J: Pancreatic ductal system obstruction and acute recurrent pancreatitis. World J Gastroenterol (2008) 14(7):1027-1033. (Pubitemid 351325001)
55. Lowes JR, Lees WR, Cotton PB: Pancreatic duct dilatation after secretin stimulation in patients with pancreas divisum. Pancreas (1989) 4(3):371-374. (Pubitemid 19140840)
56. Ng WK, Tarabain O: Pancreas divisum: a cause of idiopathic acute pancreatitis. CMAJ (2009) 180(9):949-951.